Radiotherapy Market has potential to grow by 7% of CAGR by 2023

Market Highlights

The market for the radiotherapy is increasing as the treatment is quick and easy. The treatment is more effective than chemotherapy and surgery. Though treatment has some side effects but the therapy is widely preferred by doctors. The cancerous cells get destroyed totally and do not show its presence in future. The time required is much less in contrast to the chemotherapy. The side effects of the radiotherapy are also nominal as compared to the chemotherapy.

The global radiotherapy market is growing at very significant rate and is expected show the similar trend during forecast period.

Key Market Players:

• GE Healthcare(UK),
• Siemens (Germany),
• Varian(India),
• Cardinal Health(US),
• Nordion(CA),
• Isoray(US),
• View ray (US),
• Fuji Holdings(Japan),
• Philips Healthcare (US),
• Shimadzu Corporation (Japan),
• Hologic (US).

Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/1526

View Ray, recently announced that the company has showcased its next generation MRI-guided radiation therapy solution, MRIdian Linac, at ESTRO 36, the annual meeting of the European Society for Radiotherapy and Oncology, which was held on May 5-9, 2017 in Vienna, Austria.

Isoray, company also has a new technique which into phase 3 of the clinical trials which will treat prostate cancer. The technique for the treatment is known as brachytherapy alone.

Varian, company has recently presented a new radiosurgery techniques for the optimal targeting of the multiple metastases. The metastases targeted are in the brain, spine, head & neck, and lung at the International Stereotactic Radiosurgery Society (ISRS) meeting in Montreux, Switzerland. Company has also announced that it has been selected through its distributor, Business Alignment, to supply and install a Varian ProBeam Compact single-room proton therapy system in the oncology center at King Chulalongkorn Memorial Hospital in Bangkok, Thailand. First patient treatments are expected to start in the second half of 2019.

Philips Healthcare, is a global leader in health technology, has announced the launch of IntelliSpace Oncology, a new cloud-based oncology decision-support solution that offers seamless data integration across specialties and locations, data-driven decision making, and tools for proactive patient involvement. Recently company has opened its first innovation center in Russia. The center is Located at the Skolkovo Innovation Center in Moscow. The center will have a team of scientists developing the next generation of health technologies based on computer and data science, and artificial intelligence in healthcare.

Test the market data and market information presented through more than 50 market data tables and figures spread over 80 numbers of pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Global Radiotherapy Market” Research Report – Forecast to 2023.”

Report Details @ https://www.marketresearchfuture.com/reports/radiotherapy-market-1526

The other companies also have wide presence in the home and as well as foreign countries. They also have product variety of the radiotherapy. The companies have constantly working on their R&D to innovate new techniques for the treatment of cancer. As the cancer is deadly disease which has high prevalence rate. The diagnosis is done in later stages the companies are trying to provide best equipment to treat disease in less time.

Segmentation:

The segmentation for the radiotherapy market is done on the basis of the treatment type and by application. On the basis of treatment type includes X-Ray, Gamma ray, External Beam radiotherapy, proton therapy, internal radiation therapy. The external beam radiotherapy segment is further sub-segmented into the treatment types which are 3D conformal radiation therapy, intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT), Tomotherapy, Stereotactic radio surgery, and stereotactic body radiation therapy. On the basis of the application the segment are prostate cancer, breast cancer and lung cancer, ovarian cancer and thyroid.

Make an Enquiry @ https://www.marketresearchfuture.com/enquiry/1526

Table of Content
1 Introduction
1.1 Definition
1.2 Scope Of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.2.2.1 Assumptions
1.2.2.2 Limitations
1.3 Market Structure:
2 Research Methodology
2.1 Research Process:
2.2 Primary Research
2.3 Secondary Research:
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Macroeconomic Indicators
4 Market Factor Analysis
Continued….

Browse Related Statistical Report

North America Clinical Laboratory Test Market is projected to grow at a CAGR of 5.9% and is expected to reach US$ 140,828.1 million by 2022. In North America Clinical Laboratory Test Market, US accounted for the largest market share in 2015.
North America Clinical Laboratory Test is one of the fastest growing industries. Clinical laboratory testing has emerged as the most growing segment of healthcare over the past few years.

https://www.marketresearchfuture.com/statistical-reports/north-america-clinical-laboratory-test-by-country-market-3060

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact Info:
Name: Akash Anand
Organization: Market Research Future
Address: Market Research Future Office No. 524/528,
Phone: +1 646 845 9312
Email: akash.anand@marketresearchfuture.com

This release was published on openPR.